Skip to content
Point32Health Provider
  • Home
  • Policies
    • Forms
    • Medical Benefit Drug Medical Necessity Guidelines
    • Medical Necessity Guidelines
    • Open Negotiation and Independent Dispute Resolution (No Surprises Act)
    • Payment Policies
    • Pharmacy
      • Formulary Lookup
      • Pharmacy Medical Necessity Guidelines
      • Pharmacy UM
      • Pharmacy Updates
      • Requesting authorization for pharmacy and medical drugs
    • Prior Authorization
      • Prior authorization resources
      • Vendor programs
    • Provider Manuals
      • Harvard Pilgrim Health Care Commercial Provider Manual
      • Stride Medicare Advantage Provider Manual
      • Tufts Health Plan Commercial Provider Manual
      • Tufts Health Public Plans Provider Manual
      • Tufts Health Plan Senior Products Provider Manual
  • Network & plans
    • Behavioral Health
    • Join the network
      • Join the Harvard Pilgrim Health Care network
      • Join the Tufts Health Plan network
    • Our Plans
      • Harvard Pilgrim products
        • Tiered network product resources
        • Stride Medicare Advantage Plan
      • Tufts Health Plan products
    • Quality Initiatives
      • HEDIS/Star tip sheets
      • Physician Group Honor Roll
    • Clinical Resources
      • Clinical Practice Guidelines
      • Mind the Moment for Providers
  • Office resources
    • Electronic services
      • HPHConnect
      • Tufts Health Plan Provider Portal
      • Electronic Data Interchange (EDI)
      • Electronic Funds Transfer (EFT)
    • Insights and Updates for Providers
    • News Center
    • Provider Training
  • Harvard Pilgrim Health Care Login
  • Tufts Health Plan Login

Pharmacy Medical Necessity Guidelines

The Pharmacy Medical Necessity Guidelines below detail coverage criteria for Harvard Pilgrim Health Care and Tufts Health Plan lines of business. For certain lines of business, you’ll find the pharmacy guidelines elsewhere: Tufts Medicare Preferred, Tufts Health Plan Senior Care Options, and Tufts Health One Care. You’ll also find information on Step Therapy guidelines on the Pharmacy Utilization Management page.

Tufts Health Together utilizes MassHealth’s Unified Formulary for pharmacy medications and select medical benefit drugs. In addition, for One Care, certain anti-obesity drugs are covered under MassHealth. For drug coverage and criteria refer to the MassHealth Drug List.

 

Search Filters

Clear filters All Filters

Documents in this collection

Accrufer (ferric maltol)
Commercial; Public Plans
Actemra (tocilizumab) Subcutaneous
Commercial; Public Plans
Actimmune (interferon gamma-1b)
Commercial; Public Plans
Adbry (tralokinumab-ldrm)
Commercial; Public Plans
Akynzeo (netupitant/palonosetron)
Commercial; Public Plans
Antidepressants
Commercial; Public Plans; Trintellix (vortioxetine), Pexeva (paroxetine mesylate), Zurzuvae, vilazodone
Antineoplastics
Commercial; Public Plans; Abiraterone, Alecensa (alectinib), Alunbrig (brigatinib), Augtyro (repotrectinib), Ayvakit (avapritinib), Balversa (erdafitinib), Bosulif (bosutinib), Braftovi (encorafenib), Brukinsa (zanubrutinib), Cabometyx (cabozantinib), Calquence (acalabrutinib), Caprelsa (vandetanib), Cometriq (cabozantinib), Copiktra (duvelisib), Cotellic (cobimetinib), Daurismo (glasdegib), Emcyt (estramustine), Eulexin (flutamide)Erivedge (vismodegib),Everolimus tablet, Everolimus tablets for oral suspension, Erleada (apalutamide),Exkivity (mobocertinib),Farydak (panobinostat),Fotivda (tivozanib),Fruzaqla (fruquintinib), Gavreto (pralsetinib),Gilotrif (afatinib),Ibrance (palbociclib),Iclusig (ponatinib), Idhifa (enasidenib),Imbruvica (ibrutinib),Inlyta (axitinib), Inqovi (decitabine/cedazuridine),Inrebic (fedratinib), Itovebi (inavolisib),Iwilfin (eflornithine), Jakafi (ruxolitinib), Jaypirca (pirtobrutinib), Kisqali (ribociclib),Kisqali PAK (ribociclib),Koselugo (selumetinib),Krazati (adagrasib), Lazcluze (lazertinib), Lenvima (lenvatinib),Lonsurf (trifluridine/tipiracil), Lorbrena (lorlatinib),Lumakras (sotorasib), Lynparza (olaparib),Lytgobi (futibatinib), Mekinist (trametinib),Mektovi (binimetinib),Nerlynx (neratinib), Nexavar (sorafenib),Ninlaro (ixazomib),Nubeqa (darolutamide),Odomzo (sonidegib),Ogsiveo (nirogacestat),Ojemda (tovoraenib), Ojjaara (momeotinib), Onureg (azacytidine), Orgovyx (relugolix),Orserdu (elacestrant),Pemazyre (pemigatinib),Piqray (alpelisib),Pomalyst (pomalidomide),Qinlock (ripretinib),Retevmo (selpercatinib),Revlimid (lenalidomide),Revuforj (revumenib),Rezlidhia (olutasidenib),Rozlytrek (entrectinib),Rubraca (rucaparib),Rydapt (midostaurin), Scemblix (asciminib), Sprycel (dasatinib), Stivarga (regorafenib),Tabrecta (capmatinib),Tafinlar (dabrafenib),Tagrisso (osimertinib),Talzenna (talazoparib),Tazverik (tazemetostat),Tepmetko (tepotinib),Tibsovo (ivosidenib),Truqap (capivasertib),Truseltiq (infigratinib),Tukysa (tucatinib),Turalio (pexidartinib),Vanflyta (quizartinib),Venclexta (venetoclax),Verzenio (abemaciclib),Vitrakvi (larotrectinib),Vizimpro (dacomitinib),Vonjo (pacritinib),Voranigo (vorasidenib),Welireg (belzutifan),Xalkori (crizotinib),Xospata (gilteritinib),Xpovio (selinexor),Xtandi (enzalutamide), Yonsa (abiraterone acetate),Zejula (niraparib),Zelboraf (vemurafenib),Zydelig (idelalisib), Zykadia (ceritinib)
Antiseizure Medications
Commercial; Public Plans; Epidiolex (cannabidiol), Nazyzilam (midazolam), Valtoco (diazepam), Ztalmy (ganaxolone), Libervant
Asmanex Step Therapy
Commercial; Asmanex (mometasone furoate)
Attention Deficit Hyperactivity Disorder Drugs
Commercial; Public Plans; Amphetamine (Adzenys XR-ODT, Dyanavel XR, Evekeo, Evekeo ODT), Dexmethylphenidate (Focalin, Focalin XR), Dextroamphetamine (Dexedrine, ProCentra, Zenzedi), Lisdexamfetamine (Vyvanse), Methamphetamine (Desoxyn), Methylphenidate (Adhansia XR, Aptensio XR, Concerta, Cotempla XR-ODT, Daytrana, Jornay PM, Methylin, QuilliChew ER, Quillivant XR, Relexxii, Ritalin, Ritalin LA), Serdexmethylphenidate and Dexmethylphenidate (Azstarys), Qelbree (viloxazine)
Attruby (acoramidis)
Commercial; Public Plans
Benlysta (belimumab) Subcutaneous
Commercial; Public Plans
Bepreve (bepotastine)
Commercial; Public Plans
Besremi (ropeginterferon alfa-2b-njft)
Commercial; Public Plans
Bimzelx (bimekizumab-bkzx)
Commercial; Public Plans
Bylvay (odevixibat)
Commercial; Public Plans
Cerdelga (eliglustat)
Commercial; Public Plans
Chelating and Reducing Agents
Commercial; Public Plans; Clovique, penicillamine tablets, tiopronin, trientine, Thiola (tiopronin)
Cibinqo (abrocitinib)
Commercial; Public Plans
Cimzia (certolizumab pegol)
Commercial; Public Plans
Compound Medications
Commercial; Public Plans
Crenessity (crinecerfont) oral suspension and tablets
Commercial; Public Plans
Cushing’s Disease Agents: Korlym (mifepristone), Recorlev (levoketoconazole)
Commercial; Public Plans
Cystic Fibrosis Medications
Commercial; Public Plans
Daraprim (pyrimethamine)
Commercial; Public Plans
Denavir (penciclovir) cream
Commercial; Public Plans
Dermatological Immunomodulators
Commercial; Public Plans; Elidel (pimecrolimus), Protopic (tacrolimus); betamethasone dipropionate 0.05% ointment; betamethasone valerate 0.12% foam; clobetasol 0.05% cream (emollient), lotion, shampoo, spray; desonide 0.05% cream, lotion; desoximetasone 0.25% spray; hydrocortisone 1% gel, solution; hydrocortisone valerate 0.2% ointment; triamcinolone 0.147 mg/g spray, Vtama, Zoryve
Descovy and HIV Pre-Exposure Prophylaxis (PrEP) Medications
Commercial; Public Plans
Dificid (fidaxomicin)
Commercial; Public Plans
Doxylamine-pyridoxine (Diclegis) tablets
Commercial; Public Plans

Requesting authorization:

You can request authorization one of 4 easy ways! Learn more.

 

Search tips: 

We encourage you to use the drop-down menu to filter applicability by product. We note line of business under the guideline name; keep in mind, however, that the policy may not apply to every product in that line of business. Please refer to the policy for product applicability.

© 2025 Point32Health, Inc.

 

  • Nondiscrimination Statement
  • Website Terms of Use
  • Privacy & Security
  • Accessibility Statement
  • Contact us